Lawsonia intracellularis has been identified recently as the etiological agent of proliferative enteropathies, which are characterized by intestinal epithelial hyperplasia and associated moderate immune responses. This disease complex has been reported in a broad range of animals, prevalently in pigs, and L. intracellularis has been linked with ulcerative colitis in humans. L. intracellularis is an obligate intracellular bacterium, and the pathogenic mechanisms used to cause disease are unknown. Using in vitro-grown organisms as a source of genomic DNA, we identified a Lawsonia gene which encodes a surface antigen, LsaA (for Lawsonia surface antigen), associated with attachment to and entry into cells. The deduced amino acid sequence of this protein showed some similarity to members of a novel protein family identified in a number of other bacterial pathogens but for which roles are not fully defined. Transcription of this gene was detected by reverse transcription-PCR in L. intracellularis grown in vitro in IEC18 cells and in bacteria present in ileal tissue from infected animals. Immunohistochemistry with specific monoclonal antibody and immunoblotting with sera from infected animals demonstrated that LsaA protein is synthesized by L. intracellularis during infection.
A small number of bacterial pathogens have been identified as causative agents of gastrointestinal epithelial hyperplasia. These comprise Helicobacter species (gastric hyperplasia [3, 20] ), Citrobacter rodentium (murine colonic hyperplasia [15, 16, 26, 36] ), and Lawsonia intracellularis (proliferative enteropathy [23, 40] ). L. intracellularis was only recently recognized as a pathogen and remains poorly characterized in comparison to Helicobacter species and C. rodentium. L. intracellularis is phylogenetically unrelated to other pathogens (13, 34) , but it is clearly the causative agent of proliferative enteropathies, which are infectious intestinal hyperplastic diseases of a variety of mammalian and avian species (6, 8, 23) . Presently, the disease is recognized as most significant in pigs (23, 40) ; however, the broad host range of this bacterium includes primates (in which it was recently reported to cause fatal enteritis in captive macaques 22) , and it has been suggested to have an etiological role in ulcerative colitis of humans [M. C. L. Pitcher, M. Goddard, S. McOrist, and J. H. Cummings, abstract from the Annu. Meet. Am. Gastroenterol. Assoc. 108(Suppl. 4): A894, 1995] .
L. intracellularis is an obligate intracellular bacterial enteropathogen which is most closely related to Desulfovibrio spp. (13) and Bilophila wadsworthia (41) . This relationship is based solely on 16S rRNA sequence comparisons, and further similarities between L. intracellularis and these other species have not yet been reported. Pathogenesis of L. intracellularis has not been well investigated; however, organisms cultured in vitro have been used successfully to reproduce the disease in vivo (21, 30, 32, 42, 43) . This bacterium has a tropism for intestinal epithelial cells, and the major pathological consequence of infection is hyperplasia of infected epithelial cells (23) . An interesting observation with L. intracellularis infections is the reported lack of a significant inflammatory responses (23) and little evidence for dissemination beyond the epithelium, both of which are atypical of infections with other enteroinvasive bacterial pathogens such as salmonellae, shigellae, Listeria monocytogenes, and Clostridium piliforme. The specific bacterial determinants which confer pathogenicity and cause these distinctive pathological effects are not known. Bacterial attachment and entry occur via the apical surface of immature epithelial cells in a process which appears to require a specific bacterial ligand-receptor interaction (33) and an endocytic process involving host cell actin polymerization (24) . Once inside the cell, the bacteria escape from the vacuolar compartment into the cytoplasm, where they multiply and spread from cell to cell following cell division (23) . At present, the determinants used by L. intracellularis to enter the cell, escape the vacuole, multiply intracytoplasmically, and modulate host cell function are not known.
Molecular characterization of L. intracellularis is rudimentary. Aside from reports of 16S ribosomal DNA sequence, isolation and sequence analysis of one further locus, the groES/EL operon, has been reported as a means to assess the phylogenetic position of L. intracellularis (7) . To date, however, no progress has been made in understanding the pathogenic mechanisms of this important pathogen. Despite the use of molecular technologies to further the understanding of the pathogenic mechanisms of a number of important bacterial pathogens (5, 46) , the development and use of such techniques to investigate obligately intracellular bacteria have been minimal so far. Here, we applied a range of PCR-based methodologies to identify and characterize a Lawsonia pathogenicity determinant. We sequenced, expressed, and initiated functional examinations of an L. intracellularis surface antigen, which we term LsaA. This factor demonstrated a role during attachment and entry of this bacterium into intestinal epithelial cells, and its expression was monitored in vitro and in vivo using reverse transcription-PCR (RT-PCR) and immunochemical procedures. This study represents the first study of gene expression and characterization of a pathogenicity determinant of this obligate intracellular pathogen.
(This work was presented in part at the 101st General Meeting of the American Society for Microbiology, 2001.) Semirandom PCR chromosome walking. An adaptation of a method described previously (12, 37) was used to isolate and sequence the DNA flanking the partial sequence determined by DOP-PCR. This method involved the use of 5Ј-biotinylated specific primer LI05b or LI02b (sequences are given above) derived from the partial sequence in conjunction with arbitrary primer AP1 (GGGAATTCT ATGAAGTTTATAACCCNNTGGACCGC) or AP2 (GGGAATTCTATGAA GTTTATAACCCNNNNTGCGCG). Primary PCR amplification involved 35 cycles of 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. The biotinylated PCR products generated represented a sequenced region with unknown upstream (from primer LI02b) or downstream (from primer LI05b) flanking sequence. Biotinylated single-stranded DNA molecules were immobilized on streptavidincoated paramagnetic beads (Dynabeads M-280 Streptavidin; Dynal AS, Oslo, Norway), and, following NaOH elution of the DNA, a secondary PCR was performed with nested primers LI14 or LI15 with SPI. LI14 and LI15 (TATTA TTAAAGCCTCAATTTGAAGC and GCTCAACAACTTTATAAACTTCTT, respectively) represent lsaA-specific primers (Fig. 1) , while SPI (GGGAATTC TATGAAGTTTATAACCC) represents the 25-bp segment from the 5Ј ends of both AP1 and AP2. Products obtained from this second round of PCR were analyzed by gel electrophoresis, purified, polished, and cloned into pCR Blunt II-TOPO for sequencing.
Sequencing and sequence analysis. PCR products were cloned into pCR Blunt II-TOPO or pCR 4-TOPO (Invitrogen) for automated sequencing from both strands using an ABI PRISM DYE Terminator Cycle Sequencing Kit (PerkinElmer) on a model 373A Sequence System (Applied Biosystems). Sequences obtained from overlapping products from both DOP-PCR (i.e., target gene internal fragment) and semirandom PCR chromosome walking (i.e., regions flanking the partial sequence) were assembled using DNASTAR. Data were obtained from multiple reads of the region, permitting validation of sequences obtained on different occasions. Once sequence information from overlapping PCR products was obtained, the complete lsaA gene was amplified with specifically designed primers LI19-for and LI-end1 (ATGGGGATCCATGAAAAAA AGC and CCTGCAGATATCAAGGAATATATTCTG, respectively), cloned, and sequenced for further confirmation of data. Sequence analyses were carried out using programs BLASTN, BLASTX, and CLUSTAL W (National Center for Biotechnology Information, Los Alamos, N.Mex.) available on the Internet.
Cloning, expression, and purification of recombinant LsaA. The full-length lsaA gene was amplified from Lawsonia by using primers LI19-for and LI-end1 (sequences are given above), which incorporate BamHI and PstI sites, respectively. The PCR product was ligated into pCR 4-TOPO (Invitrogen) according to the manufacturer's directions and transformed into E. coli TOP10. Plasmids were purified and, following confirmation of clones by restriction digestion and sequencing, further digested for subcloning into expression vectors. For cloning as a His fusion, pCR 4-TOPO containing complete lsaA was digested with BamHI and PstI and subjected to agarose gel electrophoresis, and the band of appropriate size was purified from the gel (GeneClean). The purified product was ligated into pRSETA (Invitrogen) which was restriction digested and purified similarly. For cloning as a glutathione S-transferase (GST) fusion, pCR 4-TOPO containing complete lsaA was digested with BamHI and EcoRI, electrophoresed, and purified as described above. The purified product was ligated into pGEX-4T-2 (Amersham Pharmacia Biotech) which was restriction digested and purified similarly. Plasmids containing inserts were termed pHLsaA and pGLsaA, respectively. The insert was sequenced to confirm both the lsaA sequence and in-frame cloning. For expression, pHLsaA and pGLsaA were transformed into E. coli BL21(DE3)pLysS or BL21, and transformants were cultured and induced as described by the supplier. His and GST fusion proteins were RT-PCR. Total RNA was extracted from purified L. intracellularis or from Lawsonia-infected pig ileum by using RNA-DNA purification columns (Qiagen). The infected pig ileal tissue was obtained from an experimental challenge of pigs performed for related investigations (30) . The methods of RNA isolation were essentially the same in both cases, although when infected tissue was used as the starting material, a more rigorous homogenization was performed. Total RNA was treated with RNase-free DNase I (Sigma) for 15 min at 37°C, after which DNase I was heat inactivated by incubation at 65°C for 10 min. RNA (100 ng) was denatured by incubation at 65°C for 10 min prior to reverse transcription in a mixture (20 l) which contained 1ϫ buffer, 5 mM deoxynucleoside triphosphates, 25 M primer, 10 U of RNase inhibitor, and 4 U of Omniscript reverse transcriptase (Qiagen) and was incubated at 37°C for 60 min. The primers LI02 and 16Srev were used to reverse transcribe Lawsonia lsaA or 16S rRNA, respectively. Ten microliters of the cDNA was then used for the PCRs with primers LI02 and LI05 for lsaA or 16Sfor and 16Srev for 16S rRNA transcripts. PCRs were carried out under standard conditions with Taq polymerase, and products were analyzed using acrylamide gel analysis to increase the sensitivity of detection (28) .
Experimental infection of animals and monitoring of infection. Experimental challenges of both mice and pigs (30, 42) were carried out for related investigations of pathogenicity and immune responses during L. intracellularis infection. Small and large intestines were removed post mortem; short regions were fixed in 10% neutral buffered formalin for immunohistochemical analysis, and the remainder was frozen rapidly and stored at Ϫ70°C for preparation of DNA and RNA (see above). Immunohistochemical detection of L. intracellularis in fixed tissues was performed as described previously (42) . Polyclonal rabbit antiserum (1080/76) or mouse monoclonal antibody VPM53 (25, 31) was used as the primary antibody, and detection was performed using the relevant secondary antibody systems (Mouse-on-Mouse or VectaStain ABC systems [Vector Labs]) according to the manufacturer's instructions. Following this, sections were counterstained with hematoxylin and then mounted in DePex (Merck). Tissues were examined histologically for features typical of L. intracellularis infection, i.e., intestinal epithelial hyperplasia and immunoreactive intracellular bacteria (L. intracellularis).
Immunoblotting. Blood from experimentally challenged and control animals (30, 42) was placed in heparinized vessels and then centrifuged (10,000 ϫ g, 1 min) to remove cellular components prior to removal of plasma to fresh vials for storage at Ϫ20°C. Plasma samples were diluted 1:200 in phosphate-buffered saline (PBS) for immunoblotting. Hyperimmune polyclonal rabbit antiserum (1080/76) and monoclonal antibody VPM53 (specific for L. intracellularis strains) were used as control antibodies. Antigen [recombinant LsaA-His fusion purified from E. coli BL21(DE3)pLysS] (approximately 2.5 g per lane) was electrophoresed on a 12.5% acrylamide gel over the whole gel width and then transferred to nitrocellulose membranes by using an Ancos Semidry blotter. Nitrocellulose membranes were assembled into a parallel blotting assembly (Bio-Rad). Molecular size standards were included routinely on gels, and after transfer to nitrocellulose membrane, lanes were excised and stained with amido black to determine molecular sizes of antigens. Incubation of membranes with primary antibody (plasma diluted 1:200) was carried out for 1 h with gentle shaking, after which it was aspirated. Wells were washed three times with PBS, and then secondary antibody (horseradish peroxidase-conjugated anti-mouse immunoglobulin; Serotec) diluted 1:4,000 was added and left for a further hour. This was removed, and membranes were washed again as described above. Membranes were then removed from the slot blot assembly, washed a further three times in PBS and once in distilled water, and then developed by addition of substrate (diaminobenzidine; Sigma). Once developed, blots were dried and photographed, and images were captured and processed as for agarose and acrylamide gels.
Hemolysin assays. Hemolysin assays were carried out in both agar and fluid formats (39) . For agar assays, E. coli clones transformed with pHLsaA or pGLsaA or vectors without insert were cultured on blood agar plates with appropriate selection and induction and monitored for hemolysis for up to 72 h. In microtiter format, purified recombinant LsaA fusion proteins (up to 100 g ml Ϫ1 ) in PBS were incubated with a 1% suspension of washed sheep erythrocytes for 2 or 24 h. Positive (PBS containing 1% Triton X-100) and negative (PBS) controls were incorporated. Following incubation, cell suspensions were centrifuged (10,000 ϫ g, 2 min) to remove unlysed cells, and then hemoglobin release was monitored by measuring absorbance at 570 nm in a spectrophotometer (Cecil CE2021).
Nucleotide sequence accession number. The nucleotide sequence of the lsaA locus has been placed in the GenBank database under accession number AF498259.
RESULTS
Initial identification of L. intracellularis locus. DOP-PCR using L. intracellularis (LR189/83) genomic DNA resulted in a product of approximately 300 bp, which corresponded to that expected from the designed primers. Following initial identification of this partial gene in L. intracellularis LR189/83, we examined other available Lawsonia isolates for the presence of this determinant. Genomic DNAs from strains LI916/91, LI1482/89 , LI51/89, and LI963/93 were extracted and used as templates in DOP-PCR. Genomic DNAs from E. coli (DH5␣) and Brachyspira hyodysenteriae were used as negative and positive controls, respectively. Products of 300 bp were amplified from all five strains of L. intracellularis examined (data not shown) and also from positive control DNA from B. hyodysenteriae, while no product was visible from the E. coli DNA.
Thus, it appears that all available L. intracellularis isolates possess the genomic region representing this locus. Having detected this locus, we proceeded to determine the sequence around this 300-bp region. Semirandom PCR chromosome walking with biotinylated specific primers allowed amplification of DNA sequences adjacent to the region initially obtained. Arbitrary primers used in conjunction with biotinylated primer LI02b or LI05b amplified upstream and downstream flanking regions, respectively. Using this approach, sequences for adjacent upstream (ca. 1-kbp) and downstream (ca. 400-bp) regions were obtained to give a region of ca. 1.7 kbp.
Sequence comparison and analysis of L. intracellularis gene product. Sequence analysis of the ca. 1.7-kbp region showed only one complete putative open reading frame (ORF) which encompassed the original DOP-PCR product. Sequence comparisons of the deduced amino acid sequence of this putative ORF using BLASTX showed some similarity with a family of bacterial proteins and putative proteins for which B. hyodysenteriae TlyA represents the prototype (27, 35, 44) . Regions upstream and downstream from this putative ORF revealed similarities to three other bacterial sequences (deoB, nusB, and nifS); however, none of these represented possible complete ORFs. Sequences with similarity to tlyA are present within the genomes of a diverse range of bacteria, including Mycoplasma pulmonis (4), Mycoplasma hyopneumoniae (GenBank accession no. AAG46052), B. hyodysenteriae (27, 35, 44) , Rickettsia prowazekii (2), Ureaplasma urealyticum (14) , Streptococcus pyogenes (10), Borrelia burgdorferi (11), Helicobacter pylori (1, 29, 45) , Campylobacter jejuni (38) , Mycobacterium tuberculosis (47) , and Mycobacterium leprae (9) . The L. intracellularis ORF showed greatest similarity to homologues in two Mycoplasma species, M. pulmonis (53.3% identity) and M. hyopneumoniae (49.6% identity), which are phylogenetically distinct from Lawsonia. Alignment of the deduced amino acid sequence of the L. intracellularis ORF with those of M. pulmonis and M. hyopneumoniae is shown in Fig. 2a .
Members of this protein family from B. hyodysenteriae (18, 19, 27, 35, 44) , H. pylori (29) , and M. tuberculosis (47) , conferred a hemolytic phenotype in native organisms and/or when cloned into E. coli; however, the activities of other members of Fig. 2b for alignment comparison) between these protein sequences is sufficient to suggest that gene products from this locus may differ in their specific activities, as is evident from this study. Indeed, since most members of this family have been deduced from genome sequencing, their expression and function remain to be fully ascertained.
Monoclonal antibody VPM53 to L. intracellularis reacted with purified recombinant ORFA-His fusion (Fig. 3) . This antibody recognized a surface protein of L. intracellularis of approximately 27 kDa (25, (31) (32) (33) , which corresponds closely to the calculated molecular mass of this gene product (27.4 kDa) based on the deduced amino acid sequence. Both the monoclonal antibody and its Fab fragment substantially inhibited L. intracellularis in vitro infectivity, to below 10 and 1%, respectively (33), indicating a role for this product in attachment to and/or invasion of intestinal epithelial cells, a phenotype which was not predicted from sequence comparison. The terminology lsaA-LsaA, for Lawsonia surface antigen A, is proposed for this gene and its product.
L. intracellularis gene expression in vitro and in vivo.
To examine whether the L. intracellularis lsaA gene was transcribed during infection in vitro and in vivo, RT-PCR was performed on total RNAs extracted from Lawsonia-infected IEC18 cells and from Lawsonia-infected pig ileal tissue. Both the IEC18 cells and the ileal tissue were positive for L. intracellularis by immunological analysis with Lawsonia-specific monoclonal antibody VPM53 (data not shown). To confirm the presence of Lawsonia, DNA was extracted from L. intracellularis-infected IEC18 cells or tissue and used as the template in an initial PCR with 16S rRNA-and lsaA-specific primers. Both genes were detected (Fig. 4a and 5a and b) , confirming that these bacteria were present and thus enabling us to proceed with the transcriptional analysis. Primers for detecting transcription of the Lawsonia 16S rRNA gene (6) were used as an intrinsic control reaction for RT-PCR, as this gene product represents a housekeeping gene which provides an essential function and is presumably transcribed constitutively during bacterial growth. To perform RT-PCR with prokaryotes with any certainty that the signal(s) obtained does indeed arise from transcripts, stringent controls need to be applied: RNA preparations were treated exhaustively with RNase-free DNase to remove residual DNA, and furthermore, in all analyses controls with no reverse transcription were included.
RT-PCR showed that 16S rRNA was transcribed in bacteria grown in IEC18 cells (Fig. 4b) ; a product of the predicted size (600 bp) was obtained, confirming the presence of metabolically active bacteria. RT-PCR with lsaA primers revealed a product of the predicted size (approximately 300 bp) (Fig. 4b) indicating transcription of this gene by replicating bacteria. No product was obtained when the reverse transcription step was omitted, confirming that the product was due to the presence of the mRNA transcript and not to contaminating DNA. Further evidence to support the specificity of the RT-PCR products was obtained by Southern blot analysis with digoxigeninlabeled 16S rRNA and lsaA probes ( Fig. 4c and d) . The 16S rRNA probe hybridized only to the 16S rRNA-derived product, and likewise, the lsaA probe hybridized only to the lsaAderived product. These findings indicated that L. intracellularis expressed 16S rRNA as well as lsaA mRNA when grown in vitro. Analysis of lsaA transcription in vivo by RT-PCR using Lawsonia-infected and uninfected pig tissue requires similar stringency. Tissues obtained from animals determined to be infected (L1 to L5) or uninfected (N1 to N4) by immunohistochemical detection (data not shown) were used for DNA and RNA extraction. Like for infected cell monolayers, the presence of 16S rRNA and lsaA genes (and hence bacteria) was determined by conventional PCR analysis with DNA as the template. Animals assessed as infected by immunohistochemistry also demonstrated the presence of 16S rRNA and lsaA PCR products, whereas uninfected animals did not (Fig. 5a and b) did not. We proceeded to examine these animals for transcripts of 16S rRNA and lsaA by using highly purified RNA extracted from the infected pig tissue. Products were obtained with both the 16S rRNA-specific and lsaAspecific primers in all samples from infected animals ( Fig. 5c and e, respectively) but not in those from uninfected animals. Again the reactions with no reverse transcription produced no products, confirming the absence of contaminating DNA. The specificity of these products was shown by Southern analysis as before (Fig. 5d  and f) . RT-PCR therefore demonstrated that Lawsonia 16S rRNA and lsaA were transcribed by these bacteria in the in vivo environment.
The region upstream from the proposed start codon of the Lawsonia lsaA was examined for motifs typical of promoter regions; however, neither conventional sigma factor consensus sites nor ribosome-binding sites were identified. This may reflect peculiarities in gene regulation and expression in this bacterium as a result of its phylogenetic position and its lifestyle. Further analysis is required to fully characterize promoter regions of this and other genes of this bacterium.
To determine whether LsaA protein was expressed by L. intracellularis during infection, two immunochemical approaches were taken. First, sera from mice experimentally infected with L. intracellularis LR189/5/83 (42) were examined by immunoblotting for antibodies to purified recombinant LsaA. The results showed that uninfected mice did not possess antibodies to this protein, whereas animals infected with L. intracellularis did (Fig. 3) . Similar results were obtained with sera from experimentally infected pigs (data not shown). The mounting of a specific serum immune response by animals orally inoculated with L. intracellularis demonstrated that this protein is indeed expressed during infection. Further evidence that LsaA was expressed during infection was obtained with monoclonal antibody VPM53, which reacted with intracellular L. intracellularis in situ in both cell culture and infected animals (Fig. 6 ). As described above, this antibody specifically recognizes LsaA (Fig. 3) , which is a ca. 27-kDa surface antigen of this bacterium. Together, the results from these immunochemical studies confirm that LsaA is expressed by L. intracellularis under both in vitro and in vivo circumstances.
DISCUSSION
Obligate intracellular bacteria represent a diverse group of organisms, among which are many important pathogens. Although genome sequencing of some has recently been completed or is under way, functional analyses must still follow. Like for other obligate intracellular bacteria, the absence of established molecular techniques for studying L. intracellularis has hindered developments in our understanding of the pathogenesis of this unique bacterium. An objective of this study was to circumvent these problems and apply methodologies to assess gene expression in this organism. Since methods for genetic manipulation of L. intracellularis (and other obligate intracellular bacteria) such as reporter fusions or mutagenesis are rudimentary, we applied PCR-based methods, as these are both specific and sensitive. These considerations are of utmost importance, as the number of bacteria available was often limiting due to the highly fastidious, obligate intracellular nature of L. intracellularis. We identified and sequenced an L. intracellularis ORF by using DOP-PCR and semirandom PCR chromosome walking and have termed this ORF lsaA, since it encodes a Lawsonia surface antigen which we have shown to be associated with attachment to and/or entry into epithelial cells. Identification of this gene was followed by examination of its expression and initial assessment of its function during infection. RT-PCR has been the method used most widely to monitor gene expression in obligate intracellular bacteria, and its application detected gene transcription by L. intracellularis in both in vitro (infected IEC18 cells) and in vivo (tissue from infected animals) environments. Our results clearly show that both genes encoding 16S rRNA and lsaA are transcribed during infection of intestinal epithelial cells in vitro (Fig. 4) . Conditions are much more complex in vivo, and expression of genes may differ from that in in vitro environments; therefore, we examined expression of these genes in ileal tissue from infected pigs. Similar to infection in vitro, transcripts specific to both 16S rRNA and lsaA were detected (Fig. 5) . Detection of 16S rRNA-and lsaAspecific transcripts indicated that these genes were expressed and suggested that both are functional during infection. The former clearly performs an essential role in protein synthesis and is presumably transcribed by metabolically active bacteria, whereas understanding of a role(s) for the latter was part of this investigation.
Although it is generally considered that transcription and translation are coupled in bacteria, expression of LsaA protein itself was assessed as a confirmatory procedure. We demonstrated that monoclonal antibody VPM53 recognized recombinant LsaA (Fig. 3) , thus facilitating the study of protein expression by immunochemical means. This anti-LsaA monoclonal antibody reacted with intracellular L. intracellularis grown in epithelial cell monolayers or in infected intestinal tissue (Fig. 6) ; thus, LsaA is expressed under conditions prevailing during both in vitro and in vivo infection. Further corroboratory evidence for expression of LsaA in vivo was obtained from animals (pigs and mice) orally inoculated with L. intracellularis: plasma from infected animals contained antibodies recognizing recombinant LsaA (Fig. 3) , thus confirming that LsaA protein was expressed by L. intracellularis during infection.
Demonstration of protein expression does not, in itself, confirm a function(s) or role(s) in pathogenesis; therefore, possible phenotypic characteristics of LsaA were assessed. The deduced amino acid sequence of LsaA was compared to sequence databases. LsaA demonstrated low, though notable, similarity to bacterial proteins within the recently identified TlyA family which are present in a range of phylogenetically diverse bacterial pathogens. Amino acid identity ranged from ca. 50% with M. pulmonis (4) and M. hyopneumoniae (GenBank accession no. AAG46052) to approximately 23% with M. leprae (9) ; thus, these proteins (and deduced proteins) show much sequence diversity, and such heterogeneity may be of significance.
Although sequence heterogeneity is evident, the presence of representatives of this protein family among these bacteria presumably reflects an important function for these bacteria. To date, homologues from only three bacterial species, i.e., B. hyodysenteriae, M. tuberculosis, and H. pylori, have been examined functionally. Among the activities conferred by TlyA cloned from these bacteria was hemolysis (18, 29, 35, 44, 47) ; however, neither recombinant E. coli clones expressing L. intracellularis LsaA nor purified recombinant LsaA protein exhibited a hemolytic phenotype. Since there is significant amino acid sequence divergence between the B. hyodysenteriae (36.7% identity [35] ), H. pylori (33.8% identity for strain 26995 [29, 45] and 31.7% identity for strain J99 [1] ), and M. tuberculosis (26.5% identity [47] ) gene products and that of L. intracellularis, this distinct phenotype should perhaps not be entirely unexpected. Recently it was proposed that rather than directly conferring a hemolytic phenotype, TlyA may be a regulatory factor (17) , a suggestion which is corroborated (29); however, a similar function has yet to be ascribed to this gene product in M. tuberculosis. These proteins evidently confer pathogenicity-associated characteristics, although specific activities and functions need to be examined further. Our own studies of phenotypic characteristics of L. intracellularis LsaA suggest a function for this protein in interaction with epithelial cells. In this study we have shown that L. intracellularis-specific monoclonal antibody VPM53 recognized LsaA, a protein of ca. 27 kDa. This monoclonal antibody also demonstrated reactivity with a bacterial outer membrane component of 27 kDa (31, 32) ; thus, LsaA is a surface-associated antigen. Furthermore, this anti-LsaA monoclonal antibody inhibited L. intracellularis infection of intestinal epithelial cells in vitro (33) , therefore blocking a specific ligand-receptor interaction, with the ligand being LsaA. Similarly, the TlyA orthologue of H. pylori was shown to have significance in adherence to gastric epithelial cells (29) , and although its direct involvement in association with epithelium was not examined, that report corroborates our own findings that members of this family may act as possible colonization factors.
Together, our accumulated information indicates that LsaA is a surface molecule of L. intracellularis which plays a role early in infection, presumably conferring adherence and/or invasion. Involvement of LsaA in attachment and/or entry was not anticipated from primary structure comparison, and with the demonstration of this phenotype, it is clear that the function(s) of this protein family requires further elucidation. Since most of the other members of this group of presumed proteins have been identified from genome sequencing, their expression remains presumptive and phenotypes remain to be examined; thus, potential role(s) has yet to be fully defined. This is the first report of an L. intracellularis factor implicated as a pathogenicity determinant, and its identification has furthered our understanding of the mechanisms of infection of this bacterium. In this study we have identified lsaA as a gene which is both transcribed and translated by L. intracellularis during infection. This is the first direct demonstration of expression of any gene in this novel species of obligate intracellular bacteria and represents a significant initial step in more detailed analyses of expression and regulation of this and other L. intracellularis genes, including those encoding potential pathogenicity determinants. Although further analysis will be required to define fully the role of this factor, our results indicate that LsaA is important in the pathogenesis of L. intracellularis, as it is evidently involved during attachment to and/or invasion of epithelial cells.
